相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
David Adams et al.
LANCET NEUROLOGY (2021)
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
Yun Chen et al.
NEURON (2021)
Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
Sanduni Wasana Jayaweera et al.
BIOMOLECULES (2021)
Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates
Diana C. Rodriguez Camargo et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study (vol 20, pg 49, 2021)
D. Adams et al.
LANCET NEUROLOGY (2021)
Apolipoprotein E impairs amyloid-β fibril elongation and maturation
Tohidul Islam et al.
FEBS JOURNAL (2020)
Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
Seyyed Abolghasem Ghadami et al.
BIOMACROMOLECULES (2020)
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease
Tosha Williams et al.
MOLECULAR NEURODEGENERATION (2020)
Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme
Liza Bergkvist et al.
PLOS ONE (2020)
Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity
Anna L. Gharibyan et al.
BIOMOLECULES (2020)
Non-polyphenolic natural inhibitors of amyloid aggregation
Liang Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease
Tiago Giao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin
Qin Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons
L. Galan-Acosta et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2020)
Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
Helen Poska et al.
SCIENTIFIC REPORTS (2020)
Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β Fibrils
Dan E. Adolfsson et al.
JOURNAL OF ORGANIC CHEMISTRY (2020)
Apolipoprotein J in Alzheimer's Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches
Seyed-Mohammad-Iman Moezzi et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
Federica Saponaro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
Aleksandra M. Wojtas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease
Gabriella T. Heller et al.
SCIENCE ADVANCES (2020)
Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study
Luka Rejc et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
Gefei Chen et al.
COMMUNICATIONS BIOLOGY (2020)
A molecular mechanism for transthyretin amyloidogenesis
Ai Woon Yee et al.
NATURE COMMUNICATIONS (2019)
The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer's Disease
Celia G. Fernandez et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Evangeline M. Foster et al.
FRONTIERS IN NEUROSCIENCE (2019)
The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
Ana-Caroline Raulin et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Antibodies against alpha-synuclein: tools and therapies
Nishant N. Vaikath et al.
JOURNAL OF NEUROCHEMISTRY (2019)
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Amaia M. Arranz et al.
LANCET NEUROLOGY (2019)
Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice
Sofia Fernandez de Retana et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregates
Tom Scheidt et al.
SCIENCE ADVANCES (2019)
Progress of immunotherapy of anti-α-synuclein in Parkinson's disease
Zhipeng Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β
Shamasree Ghosh et al.
FEBS JOURNAL (2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report
Joseph F. Arboleda-Velasquez et al.
NATURE MEDICINE (2019)
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?
Francesco Panza et al.
ANNALS OF NEUROLOGY (2019)
Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice
Simone Tambaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
Katrine L. Rasmussen et al.
ALZHEIMERS & DEMENTIA (2018)
Transthyretin Mimetics as Anti--Amyloid Agents: AComparison of Peptide and Protein Approaches
Kayla M. Pate et al.
CHEMMEDCHEM (2018)
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
Fan Liao et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Transthyretin Interferes with A beta Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates
Lina Nilsson et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells
Marie E. Oskarsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Inhibition of amyloid beta fibril formation by monomeric human transthyretin
Kanchan Garai et al.
PROTEIN SCIENCE (2018)
Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach
Nicolas Henry et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism
Qingyi Ma et al.
MOLECULAR NEURODEGENERATION (2018)
Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ
J. Scott Miners et al.
BRAIN PATHOLOGY (2017)
Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease
Fan Liao et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
Johnny Habchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways
Aleksandra M. Wojtas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions
Carl Frieden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Inhibition of curli assembly and Escherichia coli biofilm formation by the human systemic amyloid precursor transthyretin
Neha Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
Gefei Chen et al.
NATURE COMMUNICATIONS (2017)
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high density lipoproteins in bioengineered human vessels
Jerome Robert et al.
ELIFE (2017)
Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System
Joel N. Buxbaum et al.
FRONTIERS IN NEUROSCIENCE (2017)
Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia
Sara Friederike Gloeckner et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Natural product-based amyloid inhibitors
Paul Velander et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease
Mobina Alemi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET
Blaine R. Roberts et al.
BRAIN (2017)
Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review
Katrine Laura Rasmussen
ATHEROSCLEROSIS (2016)
Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila
Helen Poska et al.
BIOCHEMICAL JOURNAL (2016)
Amyloid-(1-42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
Sha Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
Alaina T. Baker-Nigh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Clusterin Binds to A1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation
Marten Beeg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
Robert W. Mahley
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
Puneet Talwar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study
Frank J. Wolters et al.
NEUROSCIENCE LETTERS (2016)
Transthyretin variants with improved inhibition of β-amyloid aggregation
Parth Mangrolia et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
Paolo Arosio et al.
NATURE COMMUNICATIONS (2016)
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
Lin Tan et al.
SCIENTIFIC REPORTS (2016)
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
Yvonne Bouter et al.
ACTA NEUROPATHOLOGICA (2015)
Dissociation of a BRICHOS trimer into monomers leads to increased inhibitory effect on Aβ42 fibril formation
Henrik Biverstal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort
Veer B. Gupta et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
Eduardo Martinez-Morillo et al.
ACTA NEUROPATHOLOGICA (2014)
Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer's Disease
Christian Schmidt et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2014)
Apolipoprotein E in Alzheimer's Disease: An Update
Jin-Tai Yu et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 37 (2014)
The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
Kanchan Garai et al.
BIOCHEMISTRY (2014)
The chaperone domain BRICHOS prevents CNS toxicity of amyloid-β peptide in Drosophila melanogaster
Erik Hermansson et al.
DISEASE MODELS & MECHANISMS (2014)
Transthyretin Stabilization by Iododiflunisal Promotes Amyloid-beta Peptide Clearance, Decreases its Deposition, and Ameliorates Cognitive Deficits in an Alzheimer's Disease Mouse Model
Carlos A. Ribeiro et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The Aβ-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain
Caroline Kerridge et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Amyloid Fibrils: Formation, Polymorphism, and Inhibition
Torleid Hard
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2014)
BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease
Marta Del Campo et al.
NEUROBIOLOGY OF AGING (2014)
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
Yadong Huang et al.
NEUROBIOLOGY OF DISEASE (2014)
Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta
Xiang Li et al.
NEUROSCIENCE BULLETIN (2014)
The BRICHOS Domain, Amyloid Fibril Formation, and Their Relationship
Stefan D. Knight et al.
BIOCHEMISTRY (2013)
Transthyretin as both a Sensor and a Scavenger of beta-Amyloid Oligomers
Dennis T. Yang et al.
BIOCHEMISTRY (2013)
Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro
Roberta Cascella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Molecular Mechanisms of Amyloid Oligomers Toxicity
Rakez Kayed et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-β Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy
Sonny Ly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mechanisms of Transthyretin Inhibition of β-Amyloid Aggregation In Vitro
Xinyi Li et al.
JOURNAL OF NEUROSCIENCE (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Concerning the structure of apoE
Carl Frieden et al.
PROTEIN SCIENCE (2013)
Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation
Carlos A. Ribeiro et al.
Current Alzheimer Research (2012)
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimers disease
Carlos Cruchaga et al.
HUMAN MOLECULAR GENETICS (2012)
Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
Bernd Bohrmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels
C. Y. Daniel Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide
Hanna Willander et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of Amyloid Formation
Torleif Hard et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide
Tadafumi Hashimoto et al.
JOURNAL OF NEUROSCIENCE (2012)
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
Afia Akram et al.
NEUROBIOLOGY OF AGING (2012)
High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C
Hanna Willander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of beta-amyloid-binding sites on transthyretin
Jiali Du et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Kawser Akter et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Increased A beta PP Processing in Familial Danish Dementia Patients
Shuji Matsuda et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?
Xinyi Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
Xinyi Li et al.
MOLECULAR NEURODEGENERATION (2011)
Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma memebrane and in endocytic vesicles
Shuji Matsuda et al.
NEUROBIOLOGY OF AGING (2011)
ISLET AMYLOID POLYPEPTIDE, ISLET AMYLOID, AND DIABETES MELLITUS
Per Westermark et al.
PHYSIOLOGICAL REVIEWS (2011)
Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-β in Human Alzheimer Brain
Phillip B. Jones et al.
PLOS ONE (2011)
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions
Jianglei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid β-peptide (Aβ1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Aβ aggregation
Siwei Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Characterization of the Interaction of β-Amyloid with Transthyretin Monomers and Tetramers
Jiali Du et al.
BIOCHEMISTRY (2010)
The transthyretin gene is expressed in Schwann cells of peripheral nerves
Tatsufumi Murakami et al.
BRAIN RESEARCH (2010)
Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1-40-mediated cell death
Ilona B. Bruinsma et al.
BRAIN RESEARCH (2010)
Memory Deficits Due to Familial British Dementia BRI2 Mutation Are Caused by Loss of BRI2 Function Rather than Amyloidosis
Robert Tamayev et al.
JOURNAL OF NEUROSCIENCE (2010)
Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits
Robert Tamayev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Clusterin: A forgotten player in Alzheimer's disease
Tapio Nuutinen et al.
BRAIN RESEARCH REVIEWS (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Insight on the Molecular Envelope of Lipid-Bound Apolipoprotein E from Electron Paramagnetic Resonance Spectroscopy
Danny M. Hatters et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
Kelly R. Bales et al.
JOURNAL OF NEUROSCIENCE (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Prevention and promotion effects of apolipoprotein E4 on amylin aggregation
Peng Lei et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Transthyretin and Amyloid in the Islets of Langerhans in Type-2 Diabetes
Gunilla T. Westermark et al.
EXPERIMENTAL DIABETES RESEARCH (2008)
Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity
R. Costa et al.
FEBS LETTERS (2008)
BRI2 (ITM2b) inhibits Aβ deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
Gilbert Gallardo et al.
NATURE NEUROSCIENCE (2008)
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals
Carina Sihlbom et al.
NEUROCHEMICAL RESEARCH (2008)
ApoE promotes the proteolytic degradation of Aβ
Qingguang Jiang et al.
NEURON (2008)
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly
Wei-Feng Xue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity
Joel N. Buxbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b
Lucas Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein aggregation processes: In search of the mechanism
Carl Frieden
PROTEIN SCIENCE (2007)
The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures
Justin J. Yerbury et al.
FASEB JOURNAL (2007)
Accelerated Aβ deposition in APPswe/PS1ΔE9 mice with hemizygous deletions of TTR (transthyretin)
Se Hoon Choi et al.
JOURNAL OF NEUROSCIENCE (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
Danny M. Hatters et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Prefibrillar amyloid aggregates could be generic toxins in higher organisms
Serena Baglioni et al.
JOURNAL OF NEUROSCIENCE (2006)
The Brichos domain-containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-Val transmembrane segment
Hanna Johansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Alzheimer disease with amygdala Lewy bodies:: A distinct form of α-synucleinopathy
Hirotake Uchikado et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The kinetics of nucleated polymerizations at high concentrations: Amyloid fibril formation near and above the supercritical concentration''
Evan T. Powers et al.
BIOPHYSICAL JOURNAL (2006)
Surfactant protein C: Its unique properties and emerging immunomodulatory role in the lung
Surafel Mulugeta et al.
MICROBES AND INFECTION (2006)
Clusterin in cerebrospinal fluid:: Analysis of carbohydrates and quantification of native and glycosylated forms
A. -M. Nilselid et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
The structure of human apolipoprotein E2, E3 and E4 in solution.: 2.: Multidomain organization correlates with the stability of apoE structure
V Clément-Collin et al.
BIOPHYSICAL CHEMISTRY (2006)
Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine
CA Peters-Libeu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sensitivity and specificity of Congo red staining according to Romhanyi. Comparison with Puchtler's or Bennhold's methods
Miklos Bely et al.
ACTA HISTOCHEMICA (2006)
Transthyretin inhibition of amylold beta aggregation and toxicity
S Giunta et al.
CLINICAL BIOCHEMISTRY (2005)
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid β (Aβ) production
A Fotinopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clusterin inhibits apoptosis by interacting with activated Bax
HL Zhang et al.
NATURE CELL BIOLOGY (2005)
Transthyretin-related familial amyloidotic polyneuropathy
Y Ando et al.
ARCHIVES OF NEUROLOGY (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain
V Raussens et al.
BIOCHEMICAL JOURNAL (2005)
Apolipoprotein E genotype regulates amyloid-β cytotoxicity
MMM Wilhelmus et al.
JOURNAL OF NEUROSCIENCE (2005)
Helix orientation of the functional domains in apolipoprotein E in discoidal high density lipoprotein particles
V Narayanaswami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants
AL Schwarzman et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2004)
Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons:: Support for the amyloid hypothesis
TD Stein et al.
JOURNAL OF NEUROSCIENCE (2004)
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization
AR Hurshman et al.
BIOCHEMISTRY (2004)
Apolipoprotein E
YD Huang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Effects of polymorphism on the lipid interaction of human apolipoprotein E
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro
MM Sousa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Clusterin
SE Jones et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Overexpression of surfactant protein-C mature peptide causes neonatal lethality in transgenic mice
JJ Conkright et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Mutations in the surfactant protein C gene associated with interstitial lung disease
LM Nogee et al.
CHEST (2002)
Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes
MM Bartl et al.
EXPERIMENTAL CELL RESEARCH (2001)
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured
X Jiang et al.
BIOCHEMISTRY (2001)
An antigen capture assay for the measurement of serum clusterin concentrations
C Morrissey et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2001)
Intrinsically disordered protein
AK Dunker et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2001)
Familial British dementia with amyloid angiopathy - Early clinical, neuropsychological and imaging findings
S Mead et al.
BRAIN (2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Clusterin is a secreted mammalian chaperone
MR Wilson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
